FI972434A0 - Farmaceutisk komposition innehållande lamotrigin - Google Patents

Farmaceutisk komposition innehållande lamotrigin

Info

Publication number
FI972434A0
FI972434A0 FI972434A FI972434A FI972434A0 FI 972434 A0 FI972434 A0 FI 972434A0 FI 972434 A FI972434 A FI 972434A FI 972434 A FI972434 A FI 972434A FI 972434 A0 FI972434 A0 FI 972434A0
Authority
FI
Finland
Prior art keywords
pct
pharmaceutical composition
composition containing
lamotrigine
containing lamotrigine
Prior art date
Application number
FI972434A
Other languages
English (en)
Finnish (fi)
Other versions
FI972434A (sv
Inventor
Simon Philip Hiskett
Susan Ann Taylor
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI972434A0 publication Critical patent/FI972434A0/sv
Publication of FI972434A publication Critical patent/FI972434A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI972434A 1994-12-07 1997-06-06 Farmaceutisk komposition innehållande lamotrigin FI972434A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9424766.5A GB9424766D0 (en) 1994-12-07 1994-12-07 Pharmaceutical composition
PCT/GB1995/002865 WO1996017611A1 (en) 1994-12-07 1995-12-07 Pharmaceutical composition comprising lamotrigine

Publications (2)

Publication Number Publication Date
FI972434A0 true FI972434A0 (sv) 1997-06-06
FI972434A FI972434A (sv) 1997-06-09

Family

ID=10765604

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972434A FI972434A (sv) 1994-12-07 1997-06-06 Farmaceutisk komposition innehållande lamotrigin

Country Status (19)

Country Link
US (1) US5861179A (sv)
EP (1) EP0797441B1 (sv)
JP (1) JP2977284B2 (sv)
CN (1) CN1174505A (sv)
AT (1) ATE213633T1 (sv)
AU (1) AU696406B2 (sv)
BR (1) BR9509975A (sv)
CA (1) CA2207284A1 (sv)
CZ (1) CZ171797A3 (sv)
DE (1) DE69525649T2 (sv)
ES (1) ES2172600T3 (sv)
FI (1) FI972434A (sv)
GB (1) GB9424766D0 (sv)
HU (1) HUT77367A (sv)
NO (1) NO972623L (sv)
NZ (1) NZ296573A (sv)
PL (1) PL320560A1 (sv)
RU (1) RU2160106C2 (sv)
WO (1) WO1996017611A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
AU1970797A (en) * 1997-02-25 1998-09-09 Procter & Gamble Company, The Wet granulating method
EP1098636A1 (en) * 1998-07-23 2001-05-16 Novo Nordisk A/S A wet granulation method for preparing a stable pharmaceutical formulation
CA2375406C (en) * 1999-06-21 2005-10-18 The Procter & Gamble Company Processes for making granular detergent in a fluidized bed granulator having recycling of improperly sized particles
JP2004526714A (ja) 2001-02-27 2004-09-02 テバ ファーマシューティカル インダストリーズ リミティド ラモトリジンの新しい結晶形およびそれらの調製方法
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
DE60312670T2 (de) * 2002-04-23 2007-12-06 Teva Pharmaceutical Industries Ltd. Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2004082587A2 (en) * 2003-03-21 2004-09-30 Ranbaxy Laboratories Limited Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004103340A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Water dispersible tablets of lamotrigine
PL3395338T3 (pl) 2003-09-12 2019-10-31 Amgen Inc Szybko rozpuszczająca się formulacja zawierająca cynakalcet HCl
US20070225727A1 (en) * 2004-05-31 2007-09-27 Keiichi Matsuhisa Transparent Tissue-Visualizng Preparation
WO2008104996A2 (en) * 2007-02-28 2008-09-04 Jubilant Organosys Limited Water dispersible pharmaceutical formulation and process for preparing the same
US20090022789A1 (en) * 2007-07-18 2009-01-22 Supernus Pharmaceuticals, Inc. Enhanced formulations of lamotrigine
CA2792046C (en) 2010-03-04 2014-12-02 Wockhardt Limited Modified release dosage form
WO2018071547A1 (en) * 2016-10-11 2018-04-19 Aucta Pharmaceuticals Powder for oral suspension containing lamotrigine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
JPS5625169A (en) * 1979-06-01 1981-03-10 Wellcome Found Triazine derivative
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
EP0406126B2 (en) * 1989-06-30 1997-12-17 Sumitomo Electric Industries, Ltd. Substrate having a superconductor layer
JP3118255B2 (ja) * 1991-01-30 2000-12-18 ザ ウエルカム ファウンデーション リミテッド 水分散性錠剤
CA2277722C (en) * 1991-11-22 2001-03-27 The Wellcome Foundation Limited Water dispersible tablets
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700114A1 (fr) * 1993-01-07 1994-07-08 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
GB9305692D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
GB9305693D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
FR2702149B1 (fr) * 1993-06-03 1995-04-07 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement du neuro-sida.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets

Also Published As

Publication number Publication date
BR9509975A (pt) 1998-06-09
JP2977284B2 (ja) 1999-11-15
NO972623D0 (no) 1997-06-06
US5861179A (en) 1999-01-19
MX9704103A (es) 1997-09-30
CN1174505A (zh) 1998-02-25
FI972434A (sv) 1997-06-09
CZ171797A3 (en) 1997-11-12
EP0797441A1 (en) 1997-10-01
JPH10510255A (ja) 1998-10-06
AU696406B2 (en) 1998-09-10
GB9424766D0 (en) 1995-02-08
CA2207284A1 (en) 1996-06-13
ATE213633T1 (de) 2002-03-15
PL320560A1 (en) 1997-10-13
DE69525649T2 (de) 2002-09-05
NZ296573A (en) 1997-08-22
ES2172600T3 (es) 2002-10-01
WO1996017611A1 (en) 1996-06-13
RU2160106C2 (ru) 2000-12-10
EP0797441B1 (en) 2002-02-27
DE69525649D1 (de) 2002-04-04
AU4121196A (en) 1996-06-26
HUT77367A (hu) 1998-03-30
NO972623L (no) 1997-08-06

Similar Documents

Publication Publication Date Title
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
FI972434A0 (sv) Farmaceutisk komposition innehållande lamotrigin
FI960102A0 (sv) En ny farmaceutisk blandning
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
FI964332A (sv) Användning av vissa metanbisfofonsyraderivat för att hindra förslappning och vandring av protes
GB9515411D0 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
UA41978C2 (uk) N-метил-n-[(1s)-1-феніл-2-((3s)-3-гідроксипіролідин-1-іл)етил]-2,2- дифенілацетамід гідрохлорид, спосіб його отримання та фармацевтична композиція
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
IL108283A0 (en) Use of riluzole for promoting restoration following radiation